Antibiotice S.A. (BVB: ATB)
Health Care · Pharmaceuticals · RO
RON2.00
+0.20% today · -19.7% 1Y
Antibiotice S.A. (BVB: ATB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $281.52M.
Over the last twelve months the share price has lost 19.7%, trading between 1.75 and 2.59.
Tweenvest scores Antibiotice S.A. across four factors: quality 72/100, value 38/100, growth 48/100, dividend 28/100. Its strongest factor is quality.
ATB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $281.52M
- Revenue (TTM)
- $134.43M
- P/E
- 165.03
- EPS
- 0.01
- Dividend yield
- 1.79%
- Beta (5Y)
- 0.21
- 52-week high
- RON2.59
- 52-week low
- RON1.75
- Avg volume (3M)
- —
- Shares outstanding
- 671.34M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fulcrum Therapeutics, Inc.NasdaqGM: FULC | $287.64M | $3.75 | -0.66% |
| Hua Medicine (Shanghai) Ltd.SEHK: 2552 | $283.77M | HK$2.23 | -4.90% |
| Tiansheng Pharmaceutical Group Co., Ltd.SZSE: 002872 | $283.43M | CN¥5.97 | -3.55% |
| Starpharma Holdings LimitedASX: SPL | $282.89M | AU$0.85 | +5.62% |
| Antengene Corporation LimitedSEHK: 6996 | $279.47M | HK$3.19 | -4.06% |
| Elite Pharmaceuticals, Inc.OTCPK: ELTP | $274.78M | $0.26 | -3.74% |
| AFT Pharmaceuticals LimitedNZSE: AFT | $272.98M | NZ$4.64 | +6.18% |
| Pharmasaga Co. Ltd.TPEX: 7878 | $272.92M | NT$163.00 | -2.10% |
Figures last refreshed Oct 11, 2026.